This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
MOUSE ANTI RAT CD147:RPE
catalog :
MCA729PE
quantity :
100 TESTS
price :
392 USD
clonality :
monoclonal
host :
mouse
conjugate :
RPE
clone name :
OX-47
reactivity :
rat
application :
flow cytometry
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA729PE
Description :
MOUSE ANTI RAT CD147:RPE
Specificity :
CD147
TargetSpecies :
Rat
Host :
Mouse
Format :
RPE
Conjugate/Tag :
RPE
Isotypes :
IgG1
Applications :
F
ApplicationTypes :
Flow Cytometry
Clone :
OX-47
Quantity :
100 TESTS
QuantityValue :
100
QuantityType :
TESTS
GOAccessions :
GO:0005515,GO:0005739,GO:0016021,GO:0005537,GO:0007566,GO:0046689,GO:0042383,GO:0042470,GO:0042475,GO:0043434,GO:0045121,GO:0046697,GO:0051591
GOTerms :
alpha-2 macroglobulin receptor-associated protein activity,GO:0045308,protein amino acid binding,protein degradation tagging activity,protein folding chaperone,protein tagging activity,mitochondria,transmembrane,mannose binding lectin,blastocyst implantation,mercuric sensitivity/resistance,response to mercuric ion,response to mercury,odontogenesis of dentin-containing tooth,odontogenesis of dentine-containing teeth,odontogeny,odontosis,tooth development,response to polypeptide hormone stimulus,GEM domain,glycolipid-enriched membrane domain,lipid raft,decidual cell reaction,response to 3',5' cAMP,response to 3',5'-cAMP,response to adenosine 3',5'-cyclophosphate,response to cyclic AMP
UniprotAccessions :
P26453
Gene :
Bsg
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=25246
PublishedSynonyms :
NEUROTHELIN
EntityFormats :
FITC,Low Endotoxin,Purified,RPE,S/N
UNSPSC :
41116161
ProductForm :
Purified IgG conjugated to R. Phycoerythrin (RPE) - lyophilized
PriceGBP :
280
PriceEUR :
392
PriceUSD :
392 USD
PriceCHF :
427.28
PriceSEK :
4120
PriceNOK :
4198
PriceDKK :
2924
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
questions and comments